Endoscopic stenting of the common bile duct allows successful treatment of a breast cancer patient with excessive liver metastases

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 6, 2004, Pages 642-643

  Eichbaum, Michael H R ^a   Schneeweiss, Andreas ^a   De Rossi, Thomas ^a   Bastert, Gunter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Hyperbilirubinaemia; Jaundice; Liver metastases; Stent

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMMON BILE DUCT; COMMON BILE DUCT STENOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; FEMALE; HUMAN; JAUNDICE; LIVER METASTASIS; RECURRENT CANCER; STENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMMON BILE DUCT; CONSTRICTION, PATHOLOGIC; ENDOSCOPY; FEMALE; FLUOROURACIL; HUMANS; HYPERBILIRUBINEMIA; LIVER NEOPLASMS; MIDDLE AGED; MITOMYCIN; PALLIATIVE CARE; STENTS;

EID: 10044267675     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000147427.30984.f7     Document Type: Article

References (4)

1. Gurevich I, Akerley W. Treatment of the jaundiced patient with breast carcinoma: case report and alternate therapeutic strategies. Cancer. 2000;91:660-663.
2. Zinser JW, Hortobagyi GN, Buzdar AU, et al. Clinical course of breast cancer patients with liver metastases. J Clin Oncol. 1987;5:773-782.
3. Pereira-Lima JC, Jakobs R, Maier M, et al. Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology. 1996;43:944-948.
4. Baillie J. Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Gastrointest Endosc. 1997;45:542.